|
Real-time Estimate
Tradegate
03:51:12 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 234.55 EUR | +32.96% |
|
0.00% | -7.43% |
| 09-28 | AbbVie Receives U.S. FDA Approval For JUVMO For Parkinson's Disease | CI |
| 09-28 | US drugmakers turn to China for licensing deals | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC. | Other Pharmaceuticals | -11.91% | 0.00% | -7.43% | -7.43% | - | 471B |
-
|
-
|
-
|
- Stock Market
- Stocks
- ABBV Stock
- 4AB Stock
- Charts AbbVie Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
